NCT00092144已完成3 期
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Clinical Effect of Oral MK0476 Vs Placebo During the Allergy Season in Patients With Seasonal Aeroallergen Sensitivity and Chronic Asthma Which is Also Active During Allergy Season
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 500
- 主要终点
- To assess daytime asthma symptoms as measured by daily diaries over a 3-week treatment period
研究概览
简要总结
The purpose of this study is to assess the efficacy and safety of an approved drug on asthma symptoms in patients with chronic asthma which is also active during the allergy season.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Asthma symptoms brought on by allergies
排除标准
- •Patient has any lung disease
- •Currently have a sinus infection or cold symptoms
结局指标
主要结局
To assess daytime asthma symptoms as measured by daily diaries over a 3-week treatment period
次要结局
- To assess the following over a 3-week treatment period:
- nighttime symptoms
- AM PEFR
- B-agonist use
- PM PEFR
- discontinuations due to asthma
- asthma attacks
研究者
相似试验
已完成
3 期
Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)Asthma, BronchialRhinitis, Allergic, PerennialNCT00092105Organon and Co58
已完成
3 期
New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe AsthmaAsthmaNCT00393952SkyePharma AG557
已完成
3 期
Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With AsthmaAsthmaNCT00393991SkyePharma AG475
已完成
2 期
Pilot Study in Patients With Symptomatic Steroid-Naive AsthmaAsthmaNCT00024544Facet Biotech120
已完成
1 期
GSK2190915 Safety and Pharmacokinetic Study in Healthy Japanese SubjectsAsthmaNCT00955383GlaxoSmithKline12